iCleanse Announces UV-C Product Licensing & Distribution Partnership with ChargeTech

March 2, 2021

iCleanse, the leader in UV-C personal device disinfection, today announces its partnership with ChargeTech, a leader in device management solutions, to combat the spread of COVID-19, expanding iCleanse’s UV-C disinfection product market reach across the Americas, Europe, and the Middle East.

ChargeTech will license iCleanse patents for ChargeTech’s existing suite of high capacity, UV-C Clean-Charge-Store Cabinets and Carts. This alliance allows iCleanse and ChargeTech to better serve the marketplace by offering the most comprehensive suite of patented chemical-free UV-C disinfection devices to combat 99.99% of pathogens, such as COVID-19.

iCleanse is the leader in chemical-free UV-C disinfection for mobile devices and the only patented solution. iCleanse’s partnership with ChargeTech will expand its reach into new markets beyond iCleanse’s industry-leading hospital network. ChargeTech’s connections with businesses across the country, in Europe, and the Middle East will help bring awareness to the power of UV-C and the importance of regularly disinfecting mobile phones and other devices to break the virus cycle.

“We are excited to announce iCleanse’s partnership with ChargeTech,” said Chris Allen, CEO of iCleanse. “They are an exceptional company of innovators with great products themselves. There is a great opportunity for us both to get our products out there to help businesses and communities battle COVID-19.”

iCleanse Product Line to be Distributed by ChargeTech

The iCleanse product line includes the Swift XL, Swift Mini, and Swift, which are engineered to control the disinfection process and adapt to a variety of venues, such as retail stores, restaurants, airports, and more.
The iCleanse product line includes:

  • iCleanse Swift XL: a patented chemical-free UV-C disinfection product for mobile devices and other personal items that kills 99.99% of pathogens, like COVID-19, in as little as 30 seconds. The Swift XL quickly disinfects multiple mobile phones and large-sized tablets simultaneously, as well as bulkier electronics and personal items, such as body cams, CB radios, stethoscopes, hairbrushes, and more. Simple to use, it comes equipped with an easy to navigate user interface to quickly start disinfection cycles or customize cycle times. The software includes notification when it’s time to replace the UV-C lamps, ensuring that devices are always properly disinfected.
  • iCleanse Swift and Swift Mini: are similar to the original popular Swift XL disinfection unit, but with a much smaller footprint. The small Swift Mini is only 15.5 inches wide and Swift is only 20 inches wide.  The Swift and Swift Mini are much more portable and versatile for hospitals and businesses without available space to sanitize devices.

“This partnership will enable us to better serve our existing corporate clients by expanding our product offering in this critically important category,” said ChargeTech CEO John Cappetta. “We were so impressed by the design and efficacy of the iCleanse products that we decided the best way to serve our customers was to expand on our large format suite of products by adding the iCleanse line or products as one of their licensed distributors. We are thrilled to expand on our CleanCharge line of large format UV-C device charging, cleaning, and storage products with the exceptional iCleanse products.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”